Industry News
Pharmaceutical Industry News
A federal district court in…
A federal district court in Delaware has taken the side of Mylan—now part of Viatris—in a patent litigation case over a proposed generic to Novo Nordisk's obesity blockbuster Wegovy. The court disputed Novo’s argument that
Device CDMO and healthcare…
Device CDMO and healthcare packaging pro Sanner is expanding its global presence with the opening of a new manufacturing facility in Greensboro, North Carolina.
Despite chronic hand eczema…
Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no specific treatment for the condition in the U.S. until the FDA signed off on Leo Pharma’s Anzupgo on Wednesday afternoon.
U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS
PEPFAR, the campaign to end H.I.V. globally, would morph into an effort to detect disease outbreaks and sell American products, according to documents obtained by The Times.
A Pill for Sleep Apnea Could Be on the Horizon
Experts say that if the new drug gets approved, it may lead to a big shift in how we treat the condition.
During a recent press tour…
During a recent press tour attended by Fierce Pharma, the importance of a homegrown biomanufacturing workforce to the North Carolina's swiftly growing life sciences industry was stressed repeatedly across universities, economic development centers and the
HHS Secretary Robert F. Kennedy…
HHS Secretary Robert F. Kennedy Jr. has signed off on a recommendation from an advisory committee to remove the preservative thimerosal from all flu shots distributed in the United States.
The FDA was set to decide on GSK’s…
The FDA was set to decide on GSK's proposed Blenrep combinations in multiple myeloma by July 23. Instead, the agency is now extending its review through October 23.
Ahead of the 10-year anniversary…
Ahead of the 10-year anniversary of Tagrisso’s original FDA approval this fall, AstraZeneca has debuted the first direct-to-consumer commercial for the lung cancer med.
Roche is pausing shipments of…
Roche is pausing shipments of Elevidys in some countries, following partner Sarepta Therapeutics’ move in the U.S., as safety concerns mount over the Duchenne muscular dystrophy gene therapy.
Genentech has executed another…
Genentech has executed another round of layoffs, eliminating 87 positions at its headquarters in South San Francisco. It is the fourth wave of job cuts from the Roche subsidiary in the last 15 months.
Operating under a new CEO and…
Operating under a new CEO and implementing a fresh turnaround strategy, Swiss CDMO Lonza appears to have closed the chapter on its sales stagnation. Meanwhile, Korea's Samsung Biologics has carried its sales growth streak through
Taiwanese drugmaker Orient Pharma…
Taiwanese drugmaker Orient Pharma has recalled 57,504 bottles of the cholesterol drug pitavastatin. Separately, Tennessee’s AvKARE recalled more than 10,000 bottles of the same drug. Both product pulls were attributed to failed impurity and degradation
A campaign backed by Kyowa Kirin,…
A campaign backed by Kyowa Kirin, Amgen and Sanofi is calling on prominent organizations with medical websites to bring their resources on women and girls with X-linked conditions up to date.
The FDA has begun accepting…
The FDA has begun accepting applications for a priority pathway designed to slash review times to one to two months, giving developers of medicines that align with U.S. national health priorities a fast track to
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.
Prescription brands are winning at…
Prescription brands are winning at awareness but losing at the pharmacy counter. Learn how GoodRx helps brands convert where it matters most.
An early July post on the TikTok…
An early July post on the TikTok account for Evofem Biosciences’ Phexxi birth control has sparked a surge in interest in the nonhormonal gel without even talking about the product—and perfectly sums up the brand’s
A Delaware jury has agreed with…
A Delaware jury has agreed with AbbVie’s claim that in creating a rival treatment for Botox, Revance Therapeutics infringed on three patents covering the formulation and manufacturing process of the mega-blockbuster. With the verdict, the
Avalyn Pharma has added on $100…
Avalyn Pharma has added on $100 million to accelerate novel inhaled versions of approved drugs for lung conditions.